Autori: Schadendorf Dirk
| Naslov | Efficacy and safety of sequencing with vemurafenib (V) plus cobimetinib (C) followed by atezolizumab (Atezo) in patients (pts) with advanced BRAF(V600)-positive melanoma: Interim analysis of the ImmunoCobiVem study. (Meeting Abstract) |
| Autori | Schadendorf Dirk ... Kandolf-Sekulovic Lidija O ... Mijuskovic Zeljko P  ... (broj koautora 20)
|
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2022), vol. 40 br. 16, Suppl. S, str. - |
| Projekat | F. Hoffmann-La Roche Ltd. |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
     |
